Age Later: Health Span, Life Span, and the New Science of Longevity book cover
Book

Age Later: Health Span, Life Span, and the New Science of Longevity

Nir Barzilai headshotNir BarzilaiDirector, Institute for Geroscience, Albert Einstein College of Medicine
Published2020
PublisherMacMillan Publishers
About the book

Health Span, Life Span, and the New Science of Longevity

How do some people avoid the slowing down, deteriorating, and weakening that plagues many of their peers decades earlier? Are they just lucky? Or do they know something the rest of us don’t? Is it possible to grow older without getting sicker? What if you could look and feel fifty through your eighties and nineties?

Founder of the Institute for Aging Research at the Albert Einstein College of Medicine and one of the leading pioneers of longevity research, Dr. Nir Barzilai’s life’s work is tackling the challenges of aging to delay and prevent the onset of all age-related diseases including “the big four”: diabetes, cancer, heart disease, and Alzheimer’s.

One of Dr. Barzilai’s most fascinating studies features volunteers that include 750 SuperAgers, individuals who maintain active lives well into their nineties and even beyond, and, more importantly, who reached that ripe old age never having experienced cardiovascular disease, cancer, diabetes, or cognitive decline.

In Age Later, Dr. Barzilai reveals the secrets his team has unlocked about SuperAgers and the scientific discoveries that show we can mimic some of their natural resistance to the aging process. This eye-opening and inspirational book will help you think of aging not as a certainty, but as a phenomenon, like many other diseases and misfortunes, that can be targeted, improved, and even cured.

Meet Nir

About Nir Barzilai

Why do some people reach 100 having spent barely any of their lives sick? Nir Barzilai, M.D. has built his career on that question. Barzilai has studied families of centenarians. Those studies have uncovered genetic variants that appear to slow the aging process and have been translated into FDA-approved drugs. His centenarians do not just live longer; they delay the onset of age-related diseases by 20 to 30 years and spend relatively little time ill at the end of life. His stated goal, the title of his talks and of a 2025 TIME profile, is to help people die young at a very old age.

His central insight is that aging itself has biological drivers that can be studied, measured and targeted, so that diabetes, cardiovascular disease, cancer, dementia and frailty need not be fought one disease at a time. Through the American Federation for Aging Research, he co-leads FAST, an ARPA-H-supported biomarker initiative, and the Super Agers initiative. He is president and co-founder of the Academy of Geroscience.

Inquiries

Bring this book to your organization

Tell us about your event and we will be in touch right away.

Step 1 submitted, your details are with us.

A few more optional questions help us come back with something specific. Skip any of them.

Format

Thank you, your inquiry is on its way.

A Stellant advisor will be in touch shortly about Nir Barzilai.

Related topics

Explore the ideas behind the book